Application | Comment | Organism |
---|---|---|
drug development | because of its central role in the overall NF-kappaB regulation, IKK-2 is a viable target for drug discovery | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expression of C-terminally FLAG-tagged wild-type and mutant IKK-2s | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
D145A | site-directed mutagenesis, the IKK-2 is devoid of kinase activity despite its ability to bind ATP with high affinity and is not phosphorylated at the T loop. mutant binds a diverse collection of inhibitors with comparable binding affinities to wild-type IKK-2, inhibition by PHA-408 is reduced compared to the wild-type enzyme | Homo sapiens |
F26A | site-directed mutagenesis, the mutant has lost the time-dependent binding of inhibitor PHA-408 | Homo sapiens |
F26W | site-directed mutagenesis | Homo sapiens |
K106N | site-directed mutagenesis | Homo sapiens |
K106Q | site-directed mutagenesis, the mutant shows time-dependent inhibition like the wild-type, inhibition by PHA-408 is slightly increased compared to the wild-type enzyme | Homo sapiens |
M96L | site-directed mutagenesis | Homo sapiens |
Y169F | site-directed mutagenesis, the mutant shows time-dependent inhibition by PHA-408 like the wild-type | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-(4-chlorophenyl)-4-ureido-1H-pyrazole-3-carboxamide | i.e. SC-108 | Homo sapiens | |
1-(benzo[d][1,3]dioxol-5-yl)-8-(3-chloroisonicotinamido)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide | i.e. PHA-379 | Homo sapiens | |
1-(benzo[d][1,3]dioxol-5-yl)-8-(5-chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-4,5-dihydro-1H-benzo-[g]indazole-3-carboxamide | i.e. PHA-250 | Homo sapiens | |
2-amino-6-(2-hydroxy-6-isobutoxyphenyl)-4-(piperidin-3-yl)nicotinonitrile | i.e. PHA-535E | Homo sapiens | |
5-((3-fluorophenyl)ethynyl)-2-ureidothiophene-3-carboxamide | i.e. PHA-966 | Homo sapiens | |
5-(4-fluorophenyl)-2-ureidothiophene-3-carboxamide | i.e. SC-440 | Homo sapiens | |
5-amino-2,30-bithiophene-4-carboxamide | i.e. SC-514 | Homo sapiens | |
additional information | structure-based design of IKK-2 inhibitors based on induced-fit docking into the homology model, overview | Homo sapiens | |
N1-(1,8-dimethylimidazo-[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine | i.e. PHA-068E | Homo sapiens | |
PHA-408 | a selective IKK-2 inhibitor, shows time-dependent binding to the enzyme | Homo sapiens |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [IkappaB protein] | Homo sapiens | - |
ADP + [IkappaB phosphoprotein] | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | O14920 | - |
- |
Purification (Comment) | Organism |
---|---|
recombinant C-terminally FLAG-tagged wild-type and mutant IKK-2s | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [biotinylated IkappaBa peptide] | i.e. biotin-Gly-Leu-Lys-Lys-Glu-Arg-Leu-Leu-Asp-Asp-Arg-His-Asp-Ser32-Gly-Leu-Asp-Ser36-Met-Lys-Asp-Glu-Glu | Homo sapiens | ADP + [biotinylated IkappaBa phosphopeptide] | - |
? | |
ATP + [IkappaB protein] | - |
Homo sapiens | ADP + [IkappaB phosphoprotein] | - |
? |
Synonyms | Comment | Organism |
---|---|---|
IkappaB kinase-2 | - |
Homo sapiens |
IKK-2 | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
25 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.6 | - |
aassay at | Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
additional information | homology molecular model of the IKK-2 kinase domain, overview | Homo sapiens |
physiological function | IKK-2 plays a central role in the overall NF-kappaB regulation | Homo sapiens |